— Know what they know.
Not Investment Advice

OCUL NASDAQ

Ocular Therapeutix, Inc.
1W: -13.5% 1M: -14.9% 3M: +5.7% YTD: -30.5% 1Y: +8.2% 3Y: +31.7% 5Y: -44.5%
$8.23
+0.01 (+0.12%)
 
Weekly Expected Move ±4.8%
$8 $9 $9 $10 $10
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 31 · $1.8B mcap · 185M float · 2.23% daily turnover · Short 40% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
36.2 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: 7972.9%
Cost Advantage
38
Intangibles
37
Switching Cost
30
Network Effect
52
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. OCUL has No discernible competitive edge (36.2/100). The business operates without significant structural advantages. The primary source of advantage is Network Effects. ROIC of 7972.9% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$26
Avg Target
$26
High
Based on 6 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 1Buy: 16Hold: 2Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$25.67
Analysts6
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-02-05 RBC Capital Lisa Walter Initiated $30 +222.8% $9.29
2025-12-08 H.C. Wainwright $19 $21 +2 +66.9% $12.58
2025-10-08 H.C. Wainwright $14 $19 +5 +64.9% $11.52
2025-10-03 Piper Sandler $15 $31 +16 +180.3% $11.06
2025-10-03 Robert W. Baird Colleen Kusy $17 $24 +7 +117.0% $11.06
2025-10-01 JMP Securities Jonathan Wolleben $19 $29 +10 +148.1% $11.69
2025-03-04 JMP Securities $24 $19 -5 +192.3% $6.50
2024-08-08 Robert W. Baird Colleen Kusy Initiated $17 +103.1% $8.37
2024-06-27 Piper Sandler Biren Amin $10 $15 +5 +123.5% $6.71
2024-06-14 H.C. Wainwright Yi Chen Initiated $14 +137.8% $5.89
2024-03-11 JMP Securities Jonathan Wolleben Initiated $24 +158.3% $9.29
2022-06-07 Piper Sandler Joseph Catanzaro Initiated $10 +164.6% $3.78

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
3
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. OCUL receives an overall rating of C-. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-02-10 D+ C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

30 Grade D
Profitability
20
Balance Sheet
31
Earnings Quality
37
Growth
22
Value
38
Momentum
27
Safety
100
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. OCUL scores highest in Safety (100/100) and lowest in Profitability (20/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
5.38
Safe Zone
Piotroski F-Score
3/9
Beneish M-Score
-2.96
Unlikely Manipulator
Ohlson O-Score
-5.87
Bankruptcy prob: 0.3%
Low Risk
Credit Rating
BBB+
Score: 64.4/100
Trend: Improving
Earnings Quality
OCF/NI: 0.78x
Accruals: -10.2%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. OCUL scores 5.38, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. OCUL scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. OCUL's score of -2.96 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. OCUL's implied 0.3% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. OCUL receives an estimated rating of BBB+ (score: 64.4/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-6.35x
PEG
0.27x
P/S
34.63x
P/B
3.17x
P/FCF
-7.88x
P/OCF
EV/EBITDA
-4.40x
EV/Revenue
23.84x
EV/EBIT
-4.33x
EV/FCF
-5.15x
Earnings Yield
-15.30%
FCF Yield
-12.69%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. OCUL currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.014
EBT / EBIT
×
EBIT Margin
-5.503
EBIT / Rev
×
Asset Turnover
0.082
Rev / Assets
×
Equity Multiplier
1.306
Assets / Equity
=
ROE
-59.9%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. OCUL's ROE of -59.9% is driven by Asset Turnover (0.082), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$8.23
Median 1Y
$6.62
5th Pctile
$1.80
95th Pctile
$24.42
Ann. Volatility
80.1%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Pravin U. Dugel,
M.D. Executive Chair, President and Chief Executive Officer
$819,200 $18,608,000 $35,946,958
Nadia Waheed, M.D.
Chief Medical Officer
$536,667 $1,091,490 $4,378,925
Donald Notman Operating
rating Officer and Chief Financial Officer
$560,175 $855,600 $3,670,959
Sanjay Nayak, M.B.B.S.,
Ph.D. Chief Strategy Officer
$510,000 $825,840 $3,463,405
Steve Meyers Commercial
ercial Officer
$510,000 $550,560 $2,550,269

CEO Pay Ratio

6077:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $35,946,958
Avg Employee Cost (SGA/emp): $5,915
Employees: 20,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
20,000
+7199.3% YoY
Revenue / Employee
$2,591
Rev: $51,823,000
Profit / Employee
$-13,297
NI: $-265,939,000
SGA / Employee
$5,915
Avg labor cost proxy
R&D / Employee
$9,855
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -2.8% -2.4% -8.0% -27.1% -39.6% -72.3% -1.2% -1.4% -1.5% -1.1% -1.3% -1.8% -2.2% -2.8% -95.2% -94.8% -1.1% -1.2% -54.9% -59.9% -59.92%
ROA -60.4% -51.9% -2.8% -9.5% -13.9% -25.4% -40.1% -50.2% -51.2% -37.9% -40.2% -57.4% -68.9% -86.9% -54.5% -54.3% -61.1% -70.3% -42.0% -45.9% -45.89%
ROIC 58.1% 62.8% 3.6% 3.5% 3.5% 3.6% 23.6% 25.0% 25.2% 24.5% 3.1% 3.4% 4.2% 5.2% 139.2% 165.4% 184.8% 203.2% 71.9% 79.7% 79.73%
ROCE -40.9% -34.7% 0.1% -8.7% -14.4% -29.4% -54.3% -69.3% -70.7% -49.2% -32.0% -46.8% -56.9% -73.5% -43.2% -43.3% -49.1% -57.0% -33.6% -37.8% -37.82%
Gross Margin 90.6% 89.2% 91.0% 90.1% 90.6% 91.0% 92.8% 90.9% 91.4% 90.9% 90.6% 91.0% 90.8% 89.9% 92.8% 88.2% 85.6% 87.8% 88.0% 87.7% 87.68%
Operating Margin -1.7% -1.6% -1.5% -1.4% -1.6% -1.8% -1.4% -1.7% -1.4% -1.3% -1.4% -2.1% -2.7% -3.0% -3.0% -6.0% -5.0% -4.7% -5.3% -8.7% -8.65%
Net Margin -72.4% 21.9% -31.3% -95.1% -1.5% -2.0% -1.1% -2.3% -1.4% -3.4% -2.0% -4.4% -2.7% -2.4% -2.8% -6.0% -5.0% -4.8% -4.9% -8.2% -8.22%
EBITDA Margin -53.0% 40.4% -13.0% -78.1% -1.3% -1.8% -93.8% -2.1% -1.2% 25.2% -1.6% -4.1% -2.4% -2.1% -2.6% -5.6% -4.7% -4.5% -4.6% -8.5% -8.54%
FCF Margin -1.8% -1.5% -1.5% -1.4% -1.2% -1.2% -1.2% -1.3% -1.4% -1.3% -1.4% -1.5% -1.6% -1.9% -2.1% -2.5% -3.2% -3.6% -4.2% -4.6% -4.63%
OCF Margin -1.8% -1.5% -1.5% -1.4% -1.2% -1.2% -1.2% -1.2% -1.3% -1.2% -1.3% -1.5% -1.5% -1.9% -2.1% -2.4% -3.1% -3.4% -3.9% -4.3% -4.35%
ROE 3Y Avg snapshot only -77.33%
ROE 5Y Avg snapshot only -1.02%
ROA 3Y Avg snapshot only -41.25%
ROIC Economic snapshot only -32.27%
Cash ROA snapshot only -27.99%
NOPAT Margin snapshot only -4.55%
Pretax Margin snapshot only -5.58%
R&D / Revenue snapshot only 4.24%
SGA / Revenue snapshot only 2.39%
SBC / Revenue snapshot only 70.37%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -11.31 -9.68 -87.63 -18.39 -10.21 -5.38 -3.27 -4.59 -4.44 -3.99 -6.01 -10.42 -8.20 -8.33 -7.42 -6.44 -7.39 -8.61 -10.18 -6.53 -6.349
P/S Ratio 36.06 22.16 13.19 8.27 6.65 6.42 4.52 7.89 7.38 4.63 8.30 20.08 18.56 23.65 22.52 20.82 28.27 38.54 52.09 36.48 34.629
P/B Ratio 15.30 11.23 6.53 4.64 3.77 3.63 6.57 11.53 11.38 7.56 5.33 13.18 12.45 15.94 4.55 3.94 5.08 6.82 4.14 2.90 3.171
P/FCF -20.05 -14.87 -8.60 -6.00 -5.60 -5.32 -3.67 -6.02 -5.13 -3.44 -5.95 -13.02 -11.84 -12.18 -10.55 -8.37 -8.93 -10.78 -12.48 -7.88 -7.878
P/OCF
EV/EBITDA -10.63 -8.66 184.66 -22.96 -9.64 -4.26 -3.14 -4.64 -4.49 -4.13 -5.61 -11.09 -8.53 -8.60 -6.35 -5.25 -6.41 -7.85 -8.20 -4.40 -4.404
EV/Revenue 30.80 17.76 10.78 6.14 4.54 4.31 3.78 7.16 6.68 3.97 6.38 18.20 16.72 21.82 17.55 15.51 22.68 32.87 39.44 23.84 23.845
EV/EBIT -10.34 -8.39 3941.57 -19.52 -8.79 -4.08 -3.04 -4.53 -4.38 -3.95 -5.37 -10.71 -8.27 -8.39 -6.22 -5.14 -6.29 -7.72 -8.06 -4.33 -4.333
EV/FCF -17.12 -11.92 -7.03 -4.45 -3.82 -3.57 -3.07 -5.45 -4.65 -2.95 -4.57 -11.80 -10.67 -11.24 -8.23 -6.23 -7.17 -9.19 -9.45 -5.15 -5.150
Earnings Yield -8.8% -10.3% -1.1% -5.4% -9.8% -18.6% -30.5% -21.8% -22.5% -25.1% -16.6% -9.6% -12.2% -12.0% -13.5% -15.5% -13.5% -11.6% -9.8% -15.3% -15.30%
FCF Yield -5.0% -6.7% -11.6% -16.7% -17.9% -18.8% -27.2% -16.6% -19.5% -29.1% -16.8% -7.7% -8.4% -8.2% -9.5% -12.0% -11.2% -9.3% -8.0% -12.7% -12.69%
PEG Ratio snapshot only 0.271
Price/Tangible Book snapshot only 2.901
EV/Gross Profit snapshot only 27.333
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 9.23 9.23 7.26 7.26 7.26 7.26 4.13 4.13 4.13 4.13 6.66 6.66 6.66 6.66 10.66 10.66 10.66 10.66 15.39 15.39 15.394
Quick Ratio 9.19 9.19 7.22 7.22 7.22 7.22 4.07 4.07 4.07 4.07 6.59 6.59 6.59 6.59 10.59 10.59 10.59 10.59 15.32 15.32 15.324
Debt/Equity 0.77 0.77 0.67 0.67 0.67 0.67 1.82 1.82 1.82 1.82 0.92 0.92 0.92 0.92 0.24 0.24 0.24 0.24 0.12 0.12 0.122
Net Debt/Equity -2.23 -2.23 -1.20 -1.20 -1.20 -1.20 -1.07 -1.07 -1.07 -1.07 -1.23 -1.23 -1.23 -1.23 -1.00 -1.00 -1.00 -1.00 -1.00 -1.00 -1.005
Debt/Assets 0.22 0.22 0.29 0.29 0.29 0.29 0.43 0.43 0.43 0.43 0.33 0.33 0.33 0.33 0.17 0.17 0.17 0.17 0.10 0.10 0.099
Debt/EBITDA -0.62 -0.74 23.22 -4.47 -2.51 -1.17 -1.04 -0.81 -0.79 -1.16 -1.26 -0.85 -0.70 -0.53 -0.43 -0.43 -0.38 -0.32 -0.32 -0.28 -0.283
Net Debt/EBITDA 1.81 2.14 -41.41 7.96 4.47 2.09 0.61 0.48 0.47 0.68 1.69 1.14 0.94 0.72 1.80 1.79 1.58 1.35 2.63 2.33 2.333
Interest Coverage -14.19 -12.15 0.02 -2.33 -3.84 -7.66 -9.12 -11.49 -11.26 -6.42 -6.12 -7.46 -8.33 -10.92 -13.25 -14.40 -16.58 -19.62 -21.47 -24.63 -24.630
Equity Multiplier 3.44 3.44 2.33 2.33 2.33 2.33 4.22 4.22 4.22 4.22 2.77 2.77 2.77 2.77 1.45 1.45 1.45 1.45 1.23 1.23 1.235
Cash Ratio snapshot only 14.507
Debt Service Coverage snapshot only -24.232
Cash to Debt snapshot only 9.238
FCF to Debt snapshot only -3.020
Defensive Interval snapshot only 812.6 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.19 0.23 0.19 0.21 0.21 0.21 0.29 0.29 0.31 0.33 0.29 0.30 0.30 0.31 0.18 0.17 0.16 0.16 0.08 0.08 0.082
Inventory Turnover 2.89 3.69 3.60 3.93 3.98 3.78 2.82 2.76 2.86 3.04 2.47 2.52 2.62 2.70 2.11 2.08 2.24 2.32 1.99 2.01 2.011
Receivables Turnover 4.36 5.21 2.61 2.96 2.99 2.98 2.43 2.43 2.57 2.72 2.46 2.52 2.57 2.59 2.18 2.04 1.94 1.90 1.65 1.65 1.651
Payables Turnover 1.04 1.33 1.21 1.32 1.33 1.27 0.93 0.92 0.95 1.01 1.11 1.13 1.18 1.22 1.31 1.30 1.40 1.45 1.58 1.59 1.594
DSO 84 70 140 123 122 123 150 150 142 134 148 145 142 141 168 179 189 192 221 221 221.1 days
DIO 126 99 102 93 92 96 130 132 128 120 148 145 139 135 173 175 163 157 183 181 181.5 days
DPO 350 274 302 277 273 287 391 398 385 361 329 322 310 300 278 281 261 252 231 229 228.9 days
Cash Conversion Cycle -140 -105 -61 -60 -60 -68 -110 -116 -115 -107 -32 -32 -29 -24 63 74 91 97 174 174 173.6 days
Fixed Asset Turnover snapshot only 2.140
Operating Cycle snapshot only 402.6 days
Cash Velocity snapshot only 0.071
Capital Intensity snapshot only 15.528
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3.4% 2.1% 1.5% 1.2% 54.6% 29.0% 18.3% 4.7% 9.4% 16.1% 13.5% 15.8% 11.9% 6.5% 9.0% -0.3% -7.3% -9.2% -18.5% -12.8% -12.76%
Net Income -0.0% 8.0% 95.8% 83.0% 68.4% 32.8% -9.8% -3.0% -1.8% -13.0% -13.7% -29.8% -52.5% -1.6% -1.4% -67.2% -56.7% -43.2% -37.4% -50.7% -50.74%
EPS 30.1% 26.0% 96.4% 82.1% 68.6% 25.4% -9.8% -3.3% -2.0% -2.2% 13.5% 23.9% 28.2% -32.6% -55.2% -30.3% -50.5% -30.0% -3.6% -13.9% -13.95%
FCF 21.6% 15.5% -22.7% -29.0% -2.1% -4.4% 5.1% 0.5% -32.4% -29.5% -28.7% -36.1% -22.0% -53.5% -66.8% -60.8% -87.3% -67.2% -59.5% -62.3% -62.33%
EBITDA -0.3% 8.5% 1.0% 89.1% 74.9% 36.4% -25.4% -5.0% -2.5% -10.4% -7.3% -23.3% -47.6% -1.8% -1.7% -79.5% -67.3% -49.8% -41.8% -59.8% -59.76%
Op. Income 12.9% -6.3% -24.2% -13.8% -9.5% -4.1% -0.8% -10.2% -11.5% -5.6% -4.7% -9.7% -36.2% -72.9% -1.1% -1.2% -99.3% -77.6% -57.2% -46.7% -46.73%
OCF Growth snapshot only -55.51%
Asset Growth snapshot only 76.46%
Equity Growth snapshot only 1.07%
Debt Growth snapshot only 5.28%
Shares Change snapshot only 32.29%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 1.5% 1.7% 1.8% 1.8% 1.9% 1.7% 1.3% 1.0% 95.9% 67.4% 49.8% 39.3% 23.7% 16.8% 13.6% 6.5% 4.3% 3.9% 0.3% 0.2% 0.23%
Revenue 5Y 78.9% 84.3% 87.3% 91.8% 92.2% 91.2% 93.0% 96.0% 93.8% 96.4% 96.6% 94.6% 95.4% 90.1% 72.0% 56.5% 50.8% 35.3% 24.4% 18.6% 18.64%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 1.7% 1.8% 1.9% 2.0% 2.3% 2.7% 1.9% 1.4% 1.2% 73.7% 51.4% 39.7% 23.9% 17.2% 14.1% 6.7% 4.0% 3.2% -1.1% -1.3% -1.31%
Gross Profit 5Y 84.2% 89.8% 93.4% 98.5% 99.0% 98.2% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.1% 1.3% 98.1% 74.7% 61.1% 37.5% 24.3% 17.8% 17.84%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 67.8% 67.8% 41.0% 41.0% 41.0% 41.0% 23.8% 23.8% 23.8% 23.8% -1.3% -1.3% -1.3% -1.3% 30.7% 30.7% 30.7% 30.7% 75.6% 75.6% 75.58%
Assets 5Y 18.9% 18.9% 22.3% 22.3% 22.3% 22.3% 21.9% 21.9% 21.9% 21.9% 28.1% 28.1% 28.1% 28.1% 42.2% 42.2% 42.2% 42.2% 25.3% 25.3% 25.28%
Equity 3Y 42.8% 42.8% 34.9% 34.9% 34.9% 34.9% 6.2% 6.2% 6.2% 6.2% 53.0% 53.0% 53.0% 53.0% 1.6% 1.6% 1.64%
Book Value 3Y 10.0% 9.9% 7.0% 9.5% 8.4% 18.9% -8.1% -7.5% -16.0% -15.1% 20.7% 20.4% 19.7% 14.5% 90.1% 85.5% 85.53%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.53 0.59 0.65 0.69 0.75 0.80 0.84 0.86 0.90 0.94 0.95 0.94 0.95 0.93 0.91 0.83 0.77 0.75 0.65 0.63 0.625
Earnings Stability 0.91 0.84 0.01 0.02 0.01 0.10 0.00 0.01 0.01 0.00 0.01 0.04 0.11 0.22 0.09 0.25 0.41 0.55 0.41 0.60 0.598
Margin Stability 0.83 0.71 0.76 0.80 0.80 0.69 0.75 0.79 0.85 0.92 0.93 0.93 0.82 0.69 0.75 0.79 0.86 0.96 0.98 0.98 0.982
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.50 0.50 0.50 0.50 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 1.00 0.97 0.50 0.50 0.50 0.87 0.50 0.50 0.50 0.95 0.95 0.88 0.50 0.50 0.50 0.50 0.50 0.83 0.85 0.50 0.500
Earnings Smoothness
ROE Trend -0.95 -1.52 -1.70 -0.98 0.16 0.12 -0.05 -0.63 0.83 1.28 1.35 1.11 0.34 0.49 0.494
Gross Margin Trend 0.29 0.31 0.23 0.19 0.13 0.05 0.02 0.01 0.01 0.01 0.00 0.00 -0.00 -0.00 0.00 -0.01 -0.02 -0.02 -0.04 -0.04 -0.036
FCF Margin Trend 18.52 16.19 9.47 6.02 4.81 2.30 1.10 0.57 0.06 0.00 -0.01 -0.20 -0.25 -0.66 -0.82 -1.06 -1.66 -1.93 -2.41 -2.61 -2.615
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.56 0.64 10.00 3.01 1.77 0.97 0.84 0.69 0.77 1.04 0.93 0.78 0.68 0.68 0.70 0.75 0.81 0.76 0.77 0.78 0.779
FCF/OCF 1.01 1.01 1.02 1.02 1.03 1.04 1.06 1.11 1.12 1.11 1.08 1.03 1.02 1.01 1.01 1.02 1.02 1.05 1.06 1.07 1.065
FCF/Net Income snapshot only 0.829
CapEx/Revenue 2.3% 2.1% 2.7% 2.7% 3.4% 4.4% 7.2% 13.2% 15.2% 13.5% 10.4% 5.0% 2.8% 2.5% 2.0% 5.0% 6.1% 16.8% 23.1% 28.3% 28.32%
CapEx/Depreciation snapshot only 3.185
Accruals Ratio -0.27 -0.19 0.25 0.19 0.11 -0.01 -0.06 -0.16 -0.12 0.02 -0.03 -0.13 -0.22 -0.28 -0.17 -0.13 -0.12 -0.17 -0.10 -0.10 -0.102
Sloan Accruals snapshot only 0.517
Cash Flow Adequacy snapshot only -15.347
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -13.9% -18.9% -0.1% -0.2% -0.2% -0.2% 0.0% 0.0% -2.2% -3.6% -24.2% -36.1% -37.5% -29.2% -22.1% -0.1% -6.1% -5.1% -20.6% -29.4% -29.39%
Total Shareholder Return -13.9% -18.9% -0.1% -0.2% -0.2% -0.2% 0.0% 0.0% -2.2% -3.6% -24.2% -36.1% -37.5% -29.2% -22.1% -0.1% -6.1% -5.1% -20.6% -29.4% -29.39%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.07 1.08 -55.07 1.43 1.26 1.13 1.11 1.09 1.09 1.16 1.16 1.13 1.12 1.09 1.08 1.07 1.06 1.05 1.05 1.01 1.014
EBIT Margin -2.98 -2.12 0.00 -0.31 -0.52 -1.06 -1.24 -1.58 -1.53 -1.01 -1.19 -1.70 -2.02 -2.60 -2.82 -3.02 -3.61 -4.26 -4.89 -5.50 -5.503
Asset Turnover 0.19 0.23 0.19 0.21 0.21 0.21 0.29 0.29 0.31 0.33 0.29 0.30 0.30 0.31 0.18 0.17 0.16 0.16 0.08 0.08 0.082
Equity Multiplier 4.70 4.70 2.84 2.84 2.84 2.84 2.87 2.87 2.87 2.87 3.17 3.17 3.17 3.17 1.75 1.75 1.75 1.75 1.31 1.31 1.306
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-1.25 $-1.03 $-0.08 $-0.27 $-0.39 $-0.77 $-0.86 $-1.15 $-1.16 $-0.79 $-0.74 $-0.87 $-0.83 $-1.04 $-1.15 $-1.14 $-1.26 $-1.36 $-1.19 $-1.30 $-1.30
Book Value/Share $0.93 $0.89 $1.07 $1.07 $1.07 $1.14 $0.43 $0.46 $0.45 $0.42 $0.84 $0.69 $0.55 $0.55 $1.88 $1.86 $1.83 $1.71 $2.94 $2.92 $2.60
Tangible Book/Share $0.93 $0.89 $1.07 $1.07 $1.07 $1.14 $0.43 $0.46 $0.45 $0.42 $0.84 $0.69 $0.55 $0.55 $1.88 $1.86 $1.83 $1.71 $2.94 $2.92 $2.92
Revenue/Share $0.39 $0.45 $0.53 $0.60 $0.60 $0.65 $0.62 $0.67 $0.70 $0.68 $0.54 $0.45 $0.37 $0.37 $0.38 $0.35 $0.33 $0.30 $0.23 $0.23 $0.23
FCF/Share $-0.71 $-0.67 $-0.81 $-0.83 $-0.72 $-0.78 $-0.76 $-0.88 $-1.01 $-0.91 $-0.75 $-0.70 $-0.58 $-0.71 $-0.81 $-0.88 $-1.04 $-1.08 $-0.97 $-1.08 $-1.08
OCF/Share $-0.70 $-0.66 $-0.80 $-0.81 $-0.70 $-0.75 $-0.72 $-0.79 $-0.90 $-0.82 $-0.69 $-0.68 $-0.57 $-0.70 $-0.80 $-0.86 $-1.02 $-1.03 $-0.92 $-1.01 $-1.01
Cash/Share $2.78 $2.67 $1.99 $1.99 $1.99 $2.13 $1.24 $1.32 $1.31 $1.20 $1.80 $1.48 $1.18 $1.17 $2.33 $2.31 $2.27 $2.13 $3.31 $3.29 $2.98
EBITDA/Share $-1.14 $-0.93 $0.03 $-0.16 $-0.28 $-0.65 $-0.75 $-1.03 $-1.04 $-0.65 $-0.61 $-0.74 $-0.72 $-0.93 $-1.05 $-1.04 $-1.16 $-1.27 $-1.12 $-1.26 $-1.26
Debt/Share $0.71 $0.68 $0.72 $0.71 $0.71 $0.77 $0.78 $0.83 $0.82 $0.76 $0.77 $0.63 $0.50 $0.50 $0.45 $0.45 $0.44 $0.41 $0.36 $0.36 $0.36
Net Debt/Share $-2.07 $-1.99 $-1.28 $-1.27 $-1.27 $-1.37 $-0.46 $-0.49 $-0.49 $-0.45 $-1.03 $-0.85 $-0.68 $-0.67 $-1.88 $-1.87 $-1.83 $-1.72 $-2.95 $-2.93 $-2.93
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 5.384
Altman Z-Prime snapshot only 11.851
Piotroski F-Score 5 5 3 4 2 5 3 4 4 1 4 5 3 3 4 3 3 3 4 3 3
Beneish M-Score 2.24 -0.86 -0.44 -0.71 -1.25 -1.84 -2.80 -3.35 -3.04 -2.27 -2.40 -2.84 -3.23 -3.41 -2.97 -2.70 -2.62 -2.94 -2.93 -2.96 -2.964
Ohlson O-Score snapshot only -5.875
ROIC (Greenblatt) snapshot only -37.90%
Net-Net WC snapshot only $2.80
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BBB+
Credit Score 33.05 33.49 25.52 27.97 28.13 28.56 26.62 26.62 26.41 26.79 29.87 36.05 29.83 36.15 57.78 49.57 61.27 63.64 64.90 64.36 64.362
Credit Grade snapshot only 8
Credit Trend snapshot only 14.787
Implied Spread (bps) snapshot only 225.000
Industry Credit Rank snapshot only 61
Sector Credit Rank snapshot only 57

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms